Specify a stock or a cryptocurrency in the search bar to get a summary
Volitionrx Ltd
VNRXVolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada. Address: 1489 West Warm Springs Road, Henderson, NV, United States, 89014
Analytics
WallStreet Target Price
3.27 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures VNRX
Dividend Analytics VNRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VNRX
Stock Valuation VNRX
Financials VNRX
Results | 2019 | Dynamics |